• Altimmune, Inc. (NASDAQ:ALT) Receives Average Rating of "Buy" from Analysts

    来源: Buzz FX / 26 2月 2025 01:26:19   America/Chicago


    Altimmune, Inc. (NASDAQ:ALT) Receives Average Rating of "Buy" from Analysts Written by MarketBeat February 26, 2025 Share Link copied to clipboard. Altimmune, Inc. ( NASDAQ:ALT - Get Free Report ) has been given an average recommendation of
    Read more...
分享